Epigenetics Clinical Translation – Registration

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit:

Memorial Deadline:

External Deadline: Wednesday 5th, September 2018


Description

Registration Deadline 2018-09-05
Application Deadline 2018-10-10
Anticipated Notice of Decision 2019-02-28
Funding Start Date 2019-02-01

This funding opportunity is a key component of the second phase of the Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC), a multi-agency, pan-Canadian initiative led by CIHR.

Decades of investment into the genetic basis of disease have led to revolutionary new insights around gene regulation, and the mechanisms through which gene and environment interactions may affect human health. Key to these is epigenetics – the study of changes in the regulation of gene activity and expression that are not dependent on gene sequence and that can be environmentally induced. Through the first phase of the CEEHRC initiative, and partnered international efforts, we have learned that many chronic and complex diseases are associated with persistent epigenetic changes. The vision of CEEHRC Phase II is to advance these epigenetic discoveries into the translational realm while continuing to build on discoveries concerning the key role of epigenetic factors in development and the influence of environmental factors on a wide range of biological functions.

The current funding opportunity is to support research regarding epigenetics in the clinical setting, demonstrating proof-of-concept utility of epigenetic changes in the context of diagnostics and potential therapeutic targets, in addition to building and fostering partnerships with relevant patients and stakeholders.

Funds Available

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

  • The total amount available for this funding opportunity is $6,000,000, enough to fund up to four grants. The maximum amount per grant is $375,000 per year for up to four years.

Partner Funding Requirements:

  • By the application deadline, applicants must secure a minimum of 50% (cash and/or in-kind) of the overall amount requested from CIHR from non-federal sources.
  • This funding does not need to match the CIHR contribution on a yearly basis.
  • Partner contributions cannot be funds that have previously been leveraged for other initiatives.

Visit CIHR’s website for additional details.


Funding Sources

Canadian Institute of Health Research (CIHR)



This opportunity was posted by: RGCS

Last modified: June 1, 2018